FDA Issues Draft Guidance on Antibiotic Use in Livestock
WASHINGTON - On Monday, June 28, the U.S. Food and Drug Administration (FDA) issued draft guidance on "the judicious use of medically important antimicrobial drugs in food-producing animals." As a guidance document, these recommendations will not carry the force of law. However, FDA has indicated the document could potentially be used as the basis for future regulations.
FDA's guidance recommends: 1) the use of medically important antimicrobial drugs in food-producing animals should be limited to those uses that are considered necessary for assuring animal health, and 2) the use of medically important antimicrobial drugs in food-producing animals should be limited to those uses that include veterinary oversight or consultation
While there is no conclusive scientific evidence indicating the judicious use of antibiotics in cattle contributes to antimicrobial resistance in humans, our industry continues to actively monitor all of the international research to ensure our policies are in line with the latest knowledge. NCBA supports actions based only on sound, peer-reviewed science and risk assessment relative to the use of antibiotics.
"Antimicrobial resistance is a multi-faceted and extremely complex issue that cannot be adequately addressed by solely focusing on the use of these medications in animal agriculture," said Dr. Elizabeth Parker, chief veterinarian. "Only by carefully evaluating antimicrobial resistance in a comprehensive manner that examines all of the peer-reviewed science related to all animal use, human use and industrial use will we effectively address this important issue."
NCBA is carefully reviewing the draft guidance and associated reports, and plans to seek additional clarity from FDA in the coming weeks.